Moreover, the levels of NF-κB activity were increased in cholinergic neurons in the basal forebrains of AD patients (Li et al., 2019), and could affect AD pathology via increased pro-inflammatory cytokines expression and amyloidogenesis (Xie et al., 2020). This evidence concerns the gene NFKB1 and Alzheimer disease.